approved EB-2 (NIW)

Graduate Researcher

Biomedical Engineering · Taiwan · 2022-05-07

Processing Time
89 days
Decision Date
2022-05-07
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in advancing stem cell and tissue engineering science to develop artificial blood and organs for practical applications in clinical medicine. His work focuses on developing three-dimensional scaffolds for generating liver tissue and gene delivery platforms for directing stem cell differentiation.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the global shortage of organ donations by developing artificial blood and organs.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of experience, 10 publications, and 190 citations demonstrating his influence in the field.

3 Balance of Interests Met

The petitioner's work in clinical medicine and tissue engineering provides significant benefits that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 10 peer-reviewed journal articles and 1 book chapter which garnered 190 citations. His work was supported by funding from the NIH and NINDS, and he provided 2 expert recommendation letters confirming his contributions to the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 51 days 2025-09-25
The petitioner proposes to develop, engineer, and refine scalable stem-cell and progenitor-cell-derived organoid systems to revolutionize human organ modeling. Her work focuses on creating miniature, lab-grown structures that replicate complex human tissues for use in drug screening, disease modeling, and patient-specific regenerative therapies.

Postdoctoral Researcher

Materials Science · China

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-03-22
The petitioner proposes to continue his research on developing synthetic biomaterials that capture key features of natural tissues. This work focuses on applications in tissue engineering, drug delivery, cell transplantation, and tissue regeneration to advance stem cell research and clinical medicine.

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.

Research Scientist

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
Washington 117 days 2023-02-01
The petitioner proposes to design technological infrastructure for new, cost-effective, industry-grade tools that interface with and house human tissue. This work focuses on advancing the development of novel disease treatments and vaccines by modeling human tissues and their response to vaccination agents.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-05-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 89 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist